Vaccines in South Korea are registered through the Ministry of Food and Drug Safety (MFDS). The process involves submitting data on safety, efficacy, and quality from preclinical and clinical trials. Manufacturers must comply with Good Manufacturing Practice (GMP) standards, and vaccines undergo rigorous evaluation, including batch testing, before receiving approval for public use.